Advertisement

Noninvasive Investigation for the Detection of Asymptomatic Ischemic Heart Disease in Cerebrovascular Patients

  • A. M. Lusa
  • S. Urbinati
  • G. Di Pasquale
  • G. Pinelli
Conference paper

Abstract

The prognosis of patients with cerebral ischemia is critically influenced by the coexistence of ischemic heart disease. Myocardial infarction and sudden death are the leading long-term causes of death in patients with ischemic cerebrovascular disease [1–6] (Table 1).

Keywords

Ischemic Heart Disease Carotid Endarterectomy Silent Myocardial Ischemia Dipyridamole Infusion Thallium Myocardial Imaging 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Whisnant JP, Cartlidge NEF, Elveback LR (1978) Carotid and vertebral basilar transient ischemic attacks. Effects on anticoagulants, hypertension and cardiac disorders. Ann Neurol 3: 107–115PubMedCrossRefGoogle Scholar
  2. 2.
    Heyden S, Heiss G, Heyman A, Tyroler AH, Hares CG, Patzsche V, Manegold C (1980) Cardiovascular mortality in transient ischemic attacks. Stroke 11: 252–255PubMedCrossRefGoogle Scholar
  3. 3.
    Simonsen N, Christiansen HD, Heltberg A, Marquardsen J, Pedersen H, Sorensen PS (1981) Long term prognosis after transient ischemic attacks. Acta Neurol Scand 63: 156–178PubMedCrossRefGoogle Scholar
  4. 4.
    Muuronen A, Kaste H (1982) Outcome of 314 patients with transient ischemic attacks. Stroke 13: 24–31PubMedCrossRefGoogle Scholar
  5. 5.
    Candelise L, Vigotti M, Fieschi C, Brambilla GL, Bono G, Conforti P, De Zanche L, Inzitari D, Mariani F, Prencipe M, Argentino C, Passero S (1986) Italian Multicenter Study on reversible cerebral ischemic attacks. VI. Prognostic factors and follow-up results. Stroke 17: 842–848PubMedCrossRefGoogle Scholar
  6. 6.
    Dexter DD Jr, Whisnant JP, Connoly DC, O’Follon WM (1987) The association of stroke and coronary heart disease: a population study. Mayo Clin Proc 62: 1077–1083PubMedCrossRefGoogle Scholar
  7. 7.
    Kannel WB, Wolf PA, Verier J (1983) Manifestations of coronary artery disease predisposing to stroke. The Framingham Study. JAMA 250: 2942–2946PubMedCrossRefGoogle Scholar
  8. 8.
    Furlan A J, Whisnant JP, Baker HL Jr (1980) Long term prognosis after carotid artery occlusion. Neurology 30: 986–988PubMedCrossRefGoogle Scholar
  9. 9.
    Kroener JM, Dorn PL, Shoor PL, Wickbom IG, Bernstein FF (1980) Prognosis of asymptomatic ulcerating carotid lesions. Arch Surg 115: 1387–1391PubMedCrossRefGoogle Scholar
  10. 10.
    Cartlidge NEF, Whisnant JP, Elveback LR (1977) Carotid and vertebral basilar transient ischemic attacks. Mayo Clin Proc 52: 117–121PubMedGoogle Scholar
  11. 11.
    Toole JF, Juson CP, Janeway R (1978) Transient ischemic attacks. A prospective study of 225 patients. Neurology 28: 746–748PubMedCrossRefGoogle Scholar
  12. 12.
    Heyman A, Wilkinson WE, Hurwitz BJ (1984) Risk of ischemic heart disease in patients with TIA. Neurology 34: 626–629PubMedCrossRefGoogle Scholar
  13. 13.
    Sirna S, Biller J, Skorton DJ, Seabold JE (1990) Cardiac evaluation of the patient with stroke. Stroke 21: 14–23PubMedCrossRefGoogle Scholar
  14. 14.
    Kent KM, Rosing Dr, Wewls CJ, Lipson L, Bonno R, Epstein S (1982) Prognosis of asymptomatic or mildly symptomatic patients with coronary artery disease. Am J Cardiol 49: 1823–1831PubMedCrossRefGoogle Scholar
  15. 15.
    Canadian Cooperative Study Group (1978) A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 299: 53–59CrossRefGoogle Scholar
  16. 16.
    Chambers BR, Norris JW (1986) Outcome in patients with asymptomatic neck bruits. N Engl J Med 315: 860–865PubMedCrossRefGoogle Scholar
  17. 17.
    Interim assessment: carotid endarterectomy (1990) Report of the American Academy of Neurology, Therapeutics and Technology Assessment Subcommittee. Neurology 40: 682–683Google Scholar
  18. 18.
    Ennix CL, Lawrie GM, Morris GC, Crawford ES, Howell JF, Reardon MJ, Weathorford SC (1979) Improved results of carotid endarterectomy in patients with symptomatic coronary artery disease. An analysis of 1546 consecutive carotid operations. Stroke 10: 122–125PubMedCrossRefGoogle Scholar
  19. 19.
    Thompson JE, Austin DJ, Patman RD (1970) Carotid endarterectomy for cerebrovascular insufficiency: long term results in 592 patients followed up for thirteen years. Ann Surg 172: 663–679PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Hertzer NR, Lees CD (1981) Fatal myocardial infarction following carotid endarterectomy: three hundred thirty-five patients followed 6–11 years after operation. Ann Surg 194: 212–218PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Lee SK, Davis CH (1989) Stroke, myocardial infarction and survival during long-term follow up after carotid endarterectomy. Surg Neurol 31: 113–119PubMedCrossRefGoogle Scholar
  22. 22.
    Yeager RA, Moneta GL, Mc Connell DB, Neuwelt EA, Taylor LM, Porter JM (1989) Analysis of risk factors for myocardial infarction following carotid endarterectomy Arch Surg 124: 1142–1145Google Scholar
  23. 23.
    Adams HP, Kassel NK, Mazuz H (1984) The patient with transient ischemic attacks: is this the time for a new therapeutic approach? Stroke 15: 371–375PubMedCrossRefGoogle Scholar
  24. 24.
    Hobbs RE, Furlan AJ (1987) Detection of coronary artery disease in patients with cerebrovascular disease. In: Furlan AJ (ed) The heart and stroke. Springer, Berlin, Heidelberg, New York, pp 357–373Google Scholar
  25. 25.
    Urbinati S, Di Pasquale G, Andreoli A, Lusa AM, Ruffini M, Lanzino G, Pinelli G (1992) Frequency and prognostic significance of silent coronary artery disease in patients with cerebral ischemia undergoing carotid endarterectomy. Am J Cardiol (in press)Google Scholar
  26. 26.
    Weiner DA, Ryan TJ, McCabe CH, Luk S, Chaitman BR, Sheffield T, Tristani F, Fischer LD (1987) Significance of silent myocardial ischemia during exercise testing in patients with coronary artery disease. Am J Cardiol 59: 725–729PubMedCrossRefGoogle Scholar
  27. 27.
    Hertzer RN, Young JR, Beven EG, Graor RA, O’Hara PJ, Ruschlaught WF, de Wolfe VG, Malgovec LC (1985) Coronary angiography in 506 patients with extracranial cerebrovascular disease. Arch Intern Med 145: 849–852Google Scholar
  28. 28.
    Sox HC, Littenberg B, Garber AM (1989) The role of exercise testing in screening for coronary artery disease. Ann Intern Med 110: 456–469PubMedCrossRefGoogle Scholar
  29. 29.
    Froelicher VF, Marcondes GD (eds) (1989) Manual of exercise testing, Year Book, ChicagoGoogle Scholar
  30. 30.
    Ellestad MH, Cooke BM, Greenberg PS (1979) Stress testing: clinical application and predictive capacity. Prog Cardiovasc Dis 21: 431–460PubMedCrossRefGoogle Scholar
  31. 31.
    The American College of Cardiology, American Heart Association Task Force on Assessment of Cardiovascular Procedures (1986) Guidelines for the exercise testing- J Am Coll Cardiol 8: 725–738Google Scholar
  32. 32.
    Froelicher VF, Thompson AJ, Wolthuis R (1977) Angiographic findings in asymptomatic aircrewmen with electrocardiographic abnormalities Am J Cardiol 39: 32–38Google Scholar
  33. 33.
    Yusuf S (1988) Design of studies to critically evaluate if detection of asymptomatic ST segment deviation (“silent ischemia”) is of medical or public health importance. In: Singh BN (ed) Silent myocardial ischemia and angina. Pergamon, New York, pp 206–222Google Scholar
  34. 34.
    Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, Colombo A, Mc Arthur D, Froelicher V (1989) Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 80: 87–98Google Scholar
  35. 35.
    Erikssen J, Thaulow E (1984) Follow up of patients with asymptomatic myocardial ischemia. In: Rutishauser W, Roskamm H (eds) Silent myocardial ischemia. Springer, Berlin, Heidelberg, New York, pp 156–164Google Scholar
  36. 36.
    Di Pasquale G, Pinelli G, Grazi P, Andreoli A, Corbelli C, Manini GL, Urbinati S, Carini GC (1988) Incidence of silent myocardial ischemia in patients with cerebral ischemia. Eur Heart J 9 [Suppl N]: 9: 104–107CrossRefGoogle Scholar
  37. 37.
    Okada RD, Glover D, Gaffney T, Williams S (1988) Myocardial kinetics of technetium-99m hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 77: 491–498PubMedCrossRefGoogle Scholar
  38. 38.
    Beller GA, Gibson RS (1987) Sensibilità, specificità e significato prognostico delle metodiche di valutazione non invasiva per la coronaropatia occulta o manifesta. Prog Cardiovasc Dis 23: 187–221Google Scholar
  39. 39.
    Iskandrian AS, Heo J (1990) Appraisal of false positive results in nuclear cardiac imaging. Am Heart J 119: 708–709PubMedCrossRefGoogle Scholar
  40. 40.
    Gould KL (1989) How accurate is thallium exercise testing for the diagnosis of coronary artery disease? J Am Coll Cardiol 14: 1487–1488PubMedCrossRefGoogle Scholar
  41. 41.
    Diamond GA (1990) How accurate is SPECT thallium scintigraphy? J Am Coll Cardiol 16: 1017–1021PubMedCrossRefGoogle Scholar
  42. 42.
    Rokey R, Rolak LA, Harati Y, Kutkna N, Verani MS (1984) Coronary artery disease in patients with cerebrovascular disease: a prospective study. Ann Neurol 16: 50–53PubMedCrossRefGoogle Scholar
  43. 43.
    Okada RD, Boucher CA, Strauss WH, Pohost GM (1980) Exercise radionuclide imaging approaches to coronary artery disease. Am J Cardiol 46: 1188–1204PubMedCrossRefGoogle Scholar
  44. 44.
    Stratmann HG, Kennedy HL (1989) Evaluation of coronary artery disease in the patients unable to exercise: alternatives to exercise stress testing. Am Heart J 117: 1344–1364PubMedCrossRefGoogle Scholar
  45. 45.
    Miura M, Tominago S, Hashimoto K (1967) Potentiation of reaction hyperemia in the coronary and femoral circulation by the selective use of 2,5, -bis(diethanolamina)-4,8-dipiperidina (5,4-d)- pyrimidine. Arzneimittelforschung 17: 976–979PubMedGoogle Scholar
  46. 46.
    Tauchert M, Behrenbeck DW, Hoetzel J, Hilger HH (1976) Ein neuer pharmakologischer Test zur Diagnose der Koronarinzuffizienz. Dtsch Med Wochenschr 101: 37–42CrossRefGoogle Scholar
  47. 47.
    Gould KL, Westcott RJ, Albro PC, Hamilton GW (1978) Noninvasive assessment of coronary stenosis by myocardial imaging during pharmacologic coronary vasodilation. II Clinical methodology and feasibility. Am J Cardiol 41: 279–287Google Scholar
  48. 48.
    Boucher CA, Brewster DC, Darling RC, Okada RD, Strauss HV, Pohost GH (1985) Determination of cardiac risk by dipyridamole thallium imaging before peripheral vascular surgery. N Engl J Med 312: 389–394PubMedCrossRefGoogle Scholar
  49. 49.
    Brewster DC, Okada RD, Strauss HV, Abbott WM, Darling RC, Boucher CA (1987) Selection of patients for preoperative coronary angiography: use of dipyridamole stress thallium myocardial imaging. J Vase Surg 2: 504–510Google Scholar
  50. 50.
    Cutler BS, Leppo JA (1987) Dipyridamole Thallium-201 scintigraphy to detect coronary artery disease before abdominal aortic surgery. J Vase Surg 5: 91–100CrossRefGoogle Scholar
  51. 51.
    Younis LT, Aguirre F, Byers S, Do well S, Barth G, Walker H, Carrachi B, Peterson G, Chaitman B (1990) Perioperative and long term prognostic value of intravenous dipyridamole thallium scintigraphy in patients with peripheral vascular disease. Am Heart J 119: 1287–1292PubMedCrossRefGoogle Scholar
  52. 52.
    Iskandrian A, Heo J, Askenase A, Segal B, Auerbach N (1988) Dipyridamole cardiac imaging. Am Heart J 115: 432–443PubMedCrossRefGoogle Scholar
  53. 53.
    Laarman GJ, Bruschke AVG, Verzijlbergen JF, Go TL, Bai ET, van der Wall EE, Ascoop CAPL (1990) Thallium-201 scintigraphy after dipyridamole infusion with low level exercise. II. Quantitative analysis vs visual analysis. Eur Heart J 11: 162—172Google Scholar
  54. 54.
    Di Pasquale G, Andreoli A, Carini GC, Dondi M, Urbinati S, Ruffini M, Pinelli G (1991) Noninvasive screening for silent ischemic heart disease in patients with cerebral ischemia: use of dipyridamole thallium myocardial imaging. Cerebrovasc Dis 1: 31–37CrossRefGoogle Scholar
  55. 55.
    Laarman GJ, Bruschke AVG, Verzijlbergen JF, Bai ET, van der Wall EE, Ascoop CAPL (1988) Efficacy of intravenous dipyridamole-thallium 201 myocardial perfusion scintigraphy. Eur Heart J 9: 1206–1214PubMedGoogle Scholar
  56. 56.
    Josephson MA, Brown BG, Hecht HS, Hopkins J, Pierce CD, Petersen RB (1982) Noninvasive detection and localization of coronary stenosis in patients: comparison of resting dipyridamole and exercise thallium 201 myocardial perfusion imaging. Am Heart J 103: 1008–1118PubMedCrossRefGoogle Scholar
  57. 57.
    Ruddy TD, Dighero HR, Newell JB, Pohost GM, Strauss HW, Okada RD, Boucher CA (1987) Quantitative analysis of dipyridamole thallium images for the detection of coronary artery disease. J Am Coll Cardiol 10: 142–149PubMedCrossRefGoogle Scholar
  58. 58.
    Okada RD, Dai YD, Boucher CA, Pohost GM (1984) Significance of increased lung thallium- 201 activity on serial cardiac images after dipyridamole treatment in coronary artery disease. Am J Cardiol 53: 470–475PubMedCrossRefGoogle Scholar
  59. 59.
    Lette J, Gagnon A, Lapointe J, Cerino M (1989) Transient mitral regurgitation: an adjunctive sign of myocardial ischemia during dipyridamole-thallium imaging. J Nucl Med 30: 1271–1272PubMedGoogle Scholar
  60. 60.
    Chouraqui P, Rodrigues EA, Berman DS, Maddahi J (1990) Significance of dipyridamole induced transient dilation of the left ventricle during thallium-201 scintigraphy in suspected coronary artery disease. Am J Cardiol 66: 689–694PubMedCrossRefGoogle Scholar
  61. 61.
    Picano E, Distante A, Masini M, Morales MA, Lattanzi F, L’Abbate A (1985) Dipyridamole- echocardiography test in effort angina pectoris. Am J Cardiol 56: 452–456PubMedCrossRefGoogle Scholar
  62. 62.
    Picano E (1989) Dipyridamole-echocardiography test: historical background and physiologic basis (review article). Eur Heart J 10: 365–376PubMedGoogle Scholar
  63. 63.
    Picano E, Lattanzi F, Masini M, Distante A (1987) Does the combination with handgrip increase the sensitivity of dipyridamole echocardiographic test? Clin Cardiol 10: 37–39PubMedCrossRefGoogle Scholar
  64. 64.
    Picano E, Lattanzi F, Masini M, Distante A, L’Abbate A (1986) High dose dipyridamole echocardiographic test in effort angina pectoris. J Am Coll Cardiol 8: 848–854PubMedCrossRefGoogle Scholar
  65. 65.
    Ranhovsky A, Kempthorne-Rawson J, and the Intravenous Dipyridamole Thallium Imaging Study Group (1990) The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Circulation 81: 1205–1209CrossRefGoogle Scholar
  66. 66.
    Verani MS, Mahmarian J J, Hixson JB, Boyce TM, Staudacher RA (1990) Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 82: 80–87PubMedCrossRefGoogle Scholar
  67. 67.
    CASS Principal investigator and their associates (1983) Coronary Artery Surgery Study (CASS). A randomized trial of coronary artery bypass surgery. Survival data. Circulation 68: 939–950CrossRefGoogle Scholar
  68. 68.
    Graor RA, Hetzer NR (1988) Management of coexistent carotid artery and coronary artery disease. Stroke 19: 1441–1444PubMedCrossRefGoogle Scholar
  69. 69.
    Newman DC, Hicks RG (1988) Combined carotid and coronary artery surgery: a review of the literature. Ann Thorac Surg 45: 574–581PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • A. M. Lusa
    • 1
  • S. Urbinati
    • 1
  • G. Di Pasquale
    • 1
  • G. Pinelli
    • 1
  1. 1.Division of CardiologyBellaria HospitalBolognaItaly

Personalised recommendations